Home About Us Events ACCELERATING RARE DISEASE TREATMENTS from Concept to Cure

ACCELERATING RARE DISEASE TREATMENTS from Concept to Cure

February 29, 2024

Virtual

LSC

Join us February 29, 2024 @ 11:00 AM EST

Rebecca Abram Director, Strategic Technical Marketing, FUJIFILM Diosynth Biotechnologies and Joanna Norman Director of Viral Gene Therapies, Process Development Operations, FUJIFILM Diosynth Biotechnologies present Accelerating Rare Disease Treatments from Concept to Cure

  • The swift progression from gene discovery to mass vaccination in the development of Covid vaccines has set a remarkable precedent. This accelerated pace prompts a reflection on how a similar expeditious approach could be applied to curative therapies for rare diseases. Contract Development and Manufacturing Organizations (CDMOs) play a pivotal role in this paradigm, offering strategies to expedite workflows, internalize critical reagents, and standardize facilities and equipment. These measures, coupled with a profound understanding of the design space for creating robust manufacturing processes and implementing supporting analytics, become essential elements in advancing these groundbreaking therapies.

Click here to register